Redwood AI Raises $3.5M to

Tackling the weeks-long bottleneck of biopharmaceutical drug synthesis, Redwood AI has secured $3.5M in new funding to advance its artificial intelligence software. The company's technology is engineered to unlock significant productivity, capable of cutting the time taken to synthesize a drug from weeks down to mere minutes. This capital infusion underscores the growing interest in AI-driven solutions that promise to revolutionize complex scientific processes and significantly accelerate the pace of drug development.